Quote:AccelPath, Inc. and Energy Innovative Products Provide Merger Update
Alert
Accelpath, Inc. (QB) (USOTC:ACLP)
Intraday Stock Chart
Today : Monday 14 April 2014
Click Here for more Accelpath, Inc. (QB) Charts.
NEW YORK, April 14, 2014 /PRNewswire/ -- AccelPath (symbol: ACLP.OB ) and Energy Innovative Products, Inc., a privately held Nevada corporation (EIP), have provided additional information regarding the status of their previously announced merger transaction.
AccelPath and EIP have entered into an Agreement and Plan of Reorganization dated as of October 24, 2013, which will result in EIP becoming a wholly-owned subsidiary of AccelPath. It is expected that the equity holders of EIP will become the holders of approximately 76% of the total outstanding capital stock, on a fully diluted basis, upon completion of the transaction. EIP has previously acquired shares of preferred stock of AccelPath representing approximately 14% of AccelPath and conversely, AccelPath has acquired shares of Common Stock of EIP representing 19% of the issued and outstanding Common Stock of EIP. For accounting and financial reporting purposes under Securities and Exchange Commission rules, the transaction is expected to be treated as a reverse merger. Management of EIP will become management of AccelPath upon completion of the transaction. A majority of the Board of Directors of the post-merger company will be represented by persons associated with EIP.
The parties anticipate the transaction will be completed within approximately the next 45 days. AccelPath has recently completed updating its filings with the SEC under the Securities and Exchange Act of 1934, as amended and believes it is now current in its filing requirements. Since execution of the agreement with AccelPath, EIP has been working towards completing an audit of its financial statements, which would be required to be filed with the SEC following the completion of the transaction, as well as completing employment and compensation agreements with its executive officers, structuring its board of directors for the post merger company and strengthening its business operations.
EIP provides a comprehensive range of energy solutions, using leading proprietary technology. EIP designs, develops and markets products which reduce energy usage in Ice Machines, Freezers, Coolers, Refrigerators and other AC induction motor applications. EIP is an approved market partner of the Con Edison Green Team and is approved vendor under the EPA's, Energy Star Partner program. In addition, EIP provides energy audits, retro-fits, and price savings in energy supply of natural gas and electricity. EIP has developed a small, easy to install, patented single-phase motor controller device known as the EIP-2 that reduces energy consumption by reducing the electricity used in an AC induction motor. The EIP controller also reduces noise while maintaining temperature levels. AC Induction Motors are the most ubiquitous energy-consuming device in the home, workplace and the food and beverage industry. It is estimated that AC Induction Motors consume 65% of all the energy used in the United States. EIP is currently working with a large utility in the Northeast portion of the United States to confirm the efficacy of its motor controller device in order to certify eligibility for purchase rebates.
Consummation of the merger is subject to usual and customary closing conditions. In addition, the parties must satisfy several other closing conditions in order to complete the merger transaction. AccelPath is required to undertake a recapitalization and restructuring of its equity and debt on terms satisfactory to EIP, and the parties are required to obtain necessary shareholder approvals for the proposed reverse merger as may be required under state law.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or AccelPath's future financial performance. Any statements that are not statements of historical fact (including without limitation statements to the effect that the Company or its management "believes", "expects", "anticipates", "plans", "intends" and similar expressions) should be considered forward looking statements that involve risks and uncertainties which could cause actual events or AccelPath's actual results to differ materially from those indicated by the forward-looking statements. There are a number of important factors that could cause AccelPath's actual results to differ materially from those indicated by the forward looking statements, including those factors described under "Risk Factors" in the Company's periodic reports filed with the U.S. Securities Exchange Commission, including its Annual Report on Form 10-K. In light of the significant risks and uncertainties inherent in the forward-looking statements included herein, the inclusion of such statements should not be regarded as a representation by the Company or any other person that the objectives and plans of the Company will be achieved. Accordingly, you are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof and may become outdated over time. AccelPath undertakes no obligation to publicly update or revise any forward-looking statement as a result of new information, future events, and changes in expectation or otherwise, except as required by law.
SOURCE AccelPath, Inc.
Copyright 2014 PR Newswire
ACLP HUGE News out today! AccelPath, Inc. and Energy
Top 10 Most Recent News Articles
Firefox Champions Privacy with Iconic Internet Campaign
Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...
Continue Reading
Sintilimab Poised for New Milestone in Melanoma Fight
An Opening Shot: NMPA's Decision Window Well, here's the latest chapter in the saga of battling advanced melanoma with some real gritty numbers behind it. Innovent Biologics has thrown its hat back in the ring with news that the China National Medical Products Administration (NMPA) has embraced a new indication application for their drug sintilimab. They're teaming it up...
Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC
Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...
Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%
Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...
Continue ReadingHCLTech Partners with Rapidus on Semiconductor Future
Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...
Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms
Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...
Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit
Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...
Continue Reading
Clarins Dazzles Austin with Skin Longevity Event
Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...
Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves
Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...
Continue Reading
Dar Global Eyes Dubai for Strategic Real Estate Moves
Tapping into Dubai's Real Estate Allure Every seasoned investor knows the real estate game ain't for the faint of heart, especially when you’re playing in a market as competitive as Dubai's. But here comes Dar Global Capital Partners (DGCP), throwing their hat into the ring with a fresh strategy centered around high-value real estate. Sure, they aren't new to the...
Continue ReadingTop 5 Most Recently Viewed Articles
Dandy® Celery Innovates Back-to-School Snacking Options
Dandy® Celery Offers Innovative Snacking for Back-to-School Dandy® Produce, a leading name in fresh celery, is here to support families as they navigate back-to-school routines. They provide a variety of quick and healthy meal and snack options. Their fresh-cut celery sticks are a perfect addition to school lunches, afterschool snacks, and even quick sides for busy...
Continue Reading
General Dynamics (GD): Navigating Aerospace Headwinds and Opportunities
General Dynamics: Current Market Dynamics General Dynamics Corporation (NYSE: GD) is widely recognized for its pivotal role in the aerospace and defense sectors. The company has a strong reputation, particularly for producing Gulfstream jets, alongside its diverse range of military and marine systems. Despite its established position, General Dynamics has been...
Continue Reading
SunCar Technology Group Inc. Enters NASDAQ Golden Dragon Index
SunCar Technology Group Inc. Achieves Milestone Inclusion SunCar Technology Group Inc. (NASDAQ: SDA), a prominent player in the cloud-based B2B automotive services and insurance sector, proudly announces its recent addition to the NASDAQ Golden Dragon China Index. This significant achievement illustrates the company's upward journey and strengthens its market positioning....
Continue Reading
Strategic Investment by BrainsWay to Enhance Mental Health Solutions
BrainsWay's Expansion Plans and Strategic Investment This investment marks BrainsWay’s entrance into the market for mental health therapies that can be administered outside of a clinic, including at home. Neurolief’s breakthrough Proliv™Rx device is pending Premarket Approval from the U.S. FDA, and if granted, it will set a precedent as the first FDA-cleared medical...
Continue Reading
Future Projections: Cosmetic Surgery Market Growth Insights
The Expanding Cosmetic Surgery Market The cosmetic surgery market is anticipated to experience significant growth over the coming years, with projections indicating an increase from USD 56.98 billion in 2024 to approximately USD 83.34 billion by 2034. This impressive growth represents a compound annual growth rate (CAGR) of 3.84% from 2024 to 2034, driven by a variety of...
Continue Reading